Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus

scientific article published on 01 February 2000

Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0022-3476(00)70109-0
P698PubMed publication ID10657833

P2093author name stringK Onel
T J Lehman
P2860cites workThe 1982 revised criteria for the classification of systemic lupus erythematosusQ29547225
Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritisQ34244145
Growth and endocrine function in children receiving long-term steroid therapy for renal diseaseQ37953503
Ischemic heart disease in systemic lupus erythematosus in the young patient: report of six casesQ39564600
Systemic lupus erythematosus in childhood: clinical manifestations and improved survival in fifty-five patientsQ40232291
A practical guide to systemic lupus erythematosus.Q40417130
Osteopenia in patients with rheumatic diseases: principles of diagnosis and therapyQ40620680
Remission of lupus nephritis with cyclophosphamide and late relapses following therapy withdrawalQ40664132
Systemic lupus erythematosus in children: the complex problems of diagnosis and treatment encountered in 101 such patients at the Mayo ClinicQ40880799
Central nervous system disease in systemic lupus erythematosus. Therapy and prognosisQ43918124
Cognitive effects of corticosteroidsQ46365917
Intermittent intravenous cyclophosphamide therapy for lupus nephritis.Q54352606
The Effect of Cyclophosphamide Pulses on Fertility in Patients With Lupus NephritisQ67470042
Systemic lupus erythematosus within the first two decades of lifeQ67544598
Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugsQ68859513
Effect of treatment on the evolution of renal abnormalities in lupus nephritisQ71438057
Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trialQ71553667
New York University/Hospital for Joint Diseases experience with intravenous cyclophosphamide treatment: efficacy in steroid unresponsive lupus nephritisQ72345760
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectsystemic lupus erythematosusQ1485
P304page(s)243-247
P577publication date2000-02-01
P1433published inThe Journal of PediatricsQ7743611
P1476titleIntermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus
P478volume136

Reverse relations

cites work (P2860)
Q39418115A comparative study of two intensified pulse cyclophosphamide remission-inducing regimens for diffuse proliferative lupus nephritis: an Egyptian experience.
Q83694284Addition of mizoribine to the prednisolone plus tacrolimus treatment regimen in a patient with lupus flare
Q39010807Advances in the care of children with lupus nephritis
Q51869354Association of cyclophosphamide use with dental developmental defects and salivary gland dysfunction in recipients of childhood antineoplastic therapy.
Q38638596Combination therapy of rituximab and mycophenolate mofetil in childhood lupus nephritis
Q34095231Cyclophosphamide and lupus nephritis: when, how, for how long?
Q44407318Cyclophosphamide therapy for lupus nephritis: poor renal survival in Arab children
Q33366672Epidemiology treatment and outcome of childhood systemic lupus erythematosus in Egypt
Q46091413Fatal infection in children with lupus nephritis treated with intravenous cyclophosphamide
Q46602225Induction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children
Q45270516Infantile systemic lupus erythematosus presenting with pulmonary hemorrhage
Q37298723Intravenous cyclophosphamide combined with steroids in pediatric onset severe lupus nephritis
Q26849746Juvenile systemic lupus erythematosus: review of clinical features and management
Q35591764Lupus nephritis in childhood: a review of 53 patients followed at a single center
Q42619537Mizoribine intermittent pulse protocol for induction therapy for systemic lupus erythematosus in children: an open-label pilot study with five newly diagnosed patients
Q43959861Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine
Q33723511Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?
Q36530181Pharmacotherapy of lupus nephritis in children: a recommended treatment approach
Q37497048Prolonged improvement of childhood onset systemic lupus erythematosus following systematic administration of rituximab and cyclophosphamide
Q38374309Reviewing the recommendations for lupus in children
Q45125883Sequential evaluation of clinical and laboratory changes amongst children suffering from lupus nephritis during intermittent intravenous cyclophosphamide therapy.
Q43281578The use of low-dose cyclophosphamide followed by AZA/MMF treatment in childhood lupus nephritis
Q39160729Treatment of pediatric-onset lupus nephritis: a proposal of optimal therapy.
Q38156915Treatment of young patients with lupus nephritis using calcineurin inhibitors
Q33342024Treatment options for juvenile-onset systemic lupus erythematosus

Search more.